Literature DB >> 22078015

A systematic review comparing hysterectomy with less-invasive treatments for abnormal uterine bleeding.

Kristen A Matteson1, Husam Abed, Thomas L Wheeler, Vivian W Sung, David D Rahn, Joseph I Schaffer, Ethan M Balk.   

Abstract

STUDY
OBJECTIVE: To compare hysterectomy with less-invasive alternatives for abnormal uterine bleeding (AUB) in 7 clinically important domains.
DESIGN: Systematic review.
SETTING: Randomized clinical trials comparing bleeding, quality of life, pain, sexual health, satisfaction, need for subsequent surgery, and adverse events between hysterectomy and less-invasive treatment options. PATIENTS: Women with AUB, predominantly from ovulatory disorders and endometrial causes.
INTERVENTIONS: Systematic review of the literature (from inception to January 2011) comparing hysterectomy with alternatives for AUB treatment. Eligible trials were extracted into standardized forms. Trials were graded with a predefined 3-level rating, and the strengths of evidence for each outcome were evaluated with the Grades for Recommendation, Assessment, Development and Evaluation system.
MEASUREMENTS AND MAIN RESULTS: Nine randomized clinical trials (18 articles) were eligible. Endometrial ablation, levonorgestrel intrauterine system, and medications were associated with lower risk of adverse events but higher risk of additional treatments than hysterectomy. Compared to ablation, hysterectomy had superior long-term pain and bleeding control. Compared with the levonorgestrel intrauterine system, hysterectomy had superior control of bleeding. No other differences between treatments were found.
CONCLUSION: Less-invasive treatment options for AUB result in improvement in quality of life but carry significant risk of retreatment caused by unsatisfactory results. Although hysterectomy is the most effective treatment for AUB, it carries the highest risk for adverse events.
Copyright © 2012 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22078015      PMCID: PMC3269666          DOI: 10.1016/j.jmig.2011.08.005

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  38 in total

1.  Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.

Authors:  R Hurskainen; J Teperi; P Rissanen; A M Aalto; S Grenman; A Kivelä; E Kujansuu; S Vuorma; M Yliskoski; J Paavonen
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

2.  FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age.

Authors:  Malcolm G Munro; Hilary O D Critchley; Michael S Broder; Ian S Fraser
Journal:  Int J Gynaecol Obstet       Date:  2011-02-22       Impact factor: 3.561

3.  Work loss associated with increased menstrual loss in the United States.

Authors:  Isabelle Côté; Philip Jacobs; David Cumming
Journal:  Obstet Gynecol       Date:  2002-10       Impact factor: 7.661

4.  Use of health services associated with increased menstrual loss in the United States.

Authors:  Isabelle Côté; Philip Jacobs; David C Cumming
Journal:  Am J Obstet Gynecol       Date:  2003-02       Impact factor: 8.661

5.  Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: predictors of outcome.

Authors:  Ritva Hurskainen; Juha Teperi; Anna-Mari Aalto; Seija Grenman; Aarre Kivelä; Erkki Kujansuu; Sirkku Vuorma; Merja Yliskoski; Pekka Rissanen; Jorma Paavonen
Journal:  Acta Obstet Gynecol Scand       Date:  2004-04       Impact factor: 3.636

6.  Health status among women with menstrual symptoms.

Authors:  Karen Barnard; Susan M Frayne; Katherine M Skinner; Lisa M Sullivan
Journal:  J Womens Health (Larchmt)       Date:  2003-11       Impact factor: 2.681

Review 7.  Menorrhagia: an update.

Authors:  M K Oehler; M C P Rees
Journal:  Acta Obstet Gynecol Scand       Date:  2003-05       Impact factor: 3.636

8.  Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomized trial.

Authors:  Errico Zupi; Fulvio Zullo; Daniela Marconi; Marco Sbracia; Massimiliano Pellicano; Eugenio Solima; Giuseppe Sorrenti
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

9.  Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial.

Authors:  Miriam Kuppermann; R Edward Varner; Robert L Summitt; Lee A Learman; Christine Ireland; Eric Vittinghoff; Anita L Stewart; Feng Lin; Holly E Richter; Jonathan Showstack; Stephen B Hulley; A Eugene Washington
Journal:  JAMA       Date:  2004-03-24       Impact factor: 56.272

10.  Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up.

Authors:  Ritva Hurskainen; Juha Teperi; Pekka Rissanen; Anna-Mari Aalto; Seija Grenman; Aarre Kivelä; Erkki Kujansuu; Sirkku Vuorma; Merja Yliskoski; Jorma Paavonen
Journal:  JAMA       Date:  2004-03-24       Impact factor: 56.272

View more
  10 in total

1.  Abnormal uterine bleeding: Taking the stress out of controlling the flow.

Authors:  Jill Blaser Farrukh; Kellie Towriss; Nora McKee
Journal:  Can Fam Physician       Date:  2015-08       Impact factor: 3.275

Review 2.  Endometrial ablation for heavy menstrual bleeding.

Authors:  Vinod Kumar; Rohan Chodankar; Janesh Kumar Gupta
Journal:  Womens Health (Lond)       Date:  2016-01-12

3.  Prevalence and knowledge of heavy menstrual bleeding among African American women.

Authors:  Erica E Marsh; Maureen E Brocks; Marissa S Ghant; Hannah S Recht; Melissa Simon
Journal:  Int J Gynaecol Obstet       Date:  2014-01-02       Impact factor: 3.561

4.  Hysterectomy and Oophorectomy in Reproductive Age: A Cross-Sectional Study from a Tertiary Care Hospital.

Authors:  Ruqaiya Shahid; Hina Abbas; Shazia Mumtaz; Fouzia Perveen; Muhammad Furqan Bari; Tazeen Raja; Shaima Memon; Naseem Ahmed; Kartar Dawani
Journal:  Cureus       Date:  2020-05-28

Review 5.  Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-11-01

6.  Indications and Route of Hysterectomy for Benign Diseases. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry No. 015/070, April 2015)

Authors:  K J Neis; W Zubke; T Römer; K Schwerdtfeger; T Schollmeyer; S Rimbach; B Holthaus; E Solomayer; B Bojahr; F Neis; C Reisenauer; B Gabriel; H Dieterich; I B Runnenbaum; W Kleine; A Strauss; M Menton; I Mylonas; M David; L-C Horn; D Schmidt; P Gaß; A T Teichmann; P Brandner; W Stummvoll; A Kuhn; M Müller; M Fehr; K Tamussino
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-04       Impact factor: 2.915

Review 7.  Effects of Hysterectomy on Sexual Function.

Authors:  Risa Lonnée-Hoffmann; Ingrid Pinas
Journal:  Curr Sex Health Rep       Date:  2014

8.  A Systematic Review of Acquired Uterine Arteriovenous Malformations: Pathophysiology, Diagnosis, and Transcatheter Treatment.

Authors:  Daniel J Yoon; Megan Jones; Jamal Al Taani; Catalin Buhimschi; Joshua D Dowell
Journal:  AJP Rep       Date:  2015-10-12

9.  A Clinicopathological Correlation of International Federation of Gynecology and Obstetrics's PALM-COEIN Classification of Abnormal Uterine Bleeding: Indian Scenario.

Authors:  Kanika Singh; Charu Agarwal; Mukta Pujani; Sujata Raychaudhuri; Nimisha Sharma; Varsha Chauhan; Raina Chawla; Rashmi Ahuja; Mitasha Singh
Journal:  J Midlife Health       Date:  2019 Jul-Sep

10.  Long-term outcome of endometrial ablation therapy with Cavaterm Thermal Balloon in patients with abnormal uterine bleeding

Authors:  Mojgan Karimi-Zarchi; Marzieh Fathi; Afsar Tabatabaie; Farimah Shamsi; Leila Allahqoli; Leila Zanbagh; Seyed Mohammad Amin Hashemipour; Liselotte Mettler
Journal:  J Turk Ger Gynecol Assoc       Date:  2019-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.